Visual field impairment captures disease burden in multiple sclerosis

2016 ◽  
Vol 263 (4) ◽  
pp. 695-702 ◽  
Author(s):  
Santiago Ortiz-Perez ◽  
Magí Andorra ◽  
Bernardo Sanchez-Dalmau ◽  
Rubén Torres–Torres ◽  
David Calbet ◽  
...  
2020 ◽  
Vol 11 ◽  
Author(s):  
Marco Kaufmann ◽  
Milo Alan Puhan ◽  
Anke Salmen ◽  
Christian P. Kamm ◽  
Zina-Mary Manjaly ◽  
...  

2007 ◽  
Vol 92 (1) ◽  
pp. 84-88 ◽  
Author(s):  
C G Kiss ◽  
T Barisani-Asenbauer ◽  
C Simader ◽  
S Maca ◽  
U Schmidt-Erfurth

1980 ◽  
Vol 43 (3) ◽  
pp. 205-209 ◽  
Author(s):  
V H Patterson ◽  
J R Heron

Author(s):  
Kirstin Nygren ◽  
Gail Hartley

At each point across the disease spectrum, the MS nurse plays a pivotal role in the symptom management and comprehensive care of patients with multiple sclerosis. Multiple sclerosis most often affects young adults in the prime of life, derailing and interrupting goals and plans for the future. Whereas a neurologist might look at the disease burden of the brain, the MS nurse looks at the burden on a patient’s life. This nursing approach enables the MS nurse to help patients adjust and adapt to changes and symptoms as disease progression occurs and to empower them to live with the highest quality of life possible. As patients adjust to major life changes or advancing levels of disability, MS nurses can offer support and instill a sense of hope. This support is also important in promoting empowerment and wellness for persons with MS.


2019 ◽  
Vol 26 (12) ◽  
pp. 1497-1509 ◽  
Author(s):  
Elena Herranz ◽  
Céline Louapre ◽  
Constantina Andrada Treaba ◽  
Sindhuja T Govindarajan ◽  
Russell Ouellette ◽  
...  

Background: Neuroinflammation with microglia activation is thought to be closely related to cortical multiple sclerosis (MS) lesion pathogenesis. Objective: Using 11C-PBR28 and 7 Tesla (7T) imaging, we assessed in 9 relapsing–remitting multiple sclerosis (RRMS) and 10 secondary progressive multiple sclerosis (SPMS) patients the following: (1) microglia activation in lesioned and normal-appearing cortex, (2) cortical lesion inflammatory profiles, and (3) the relationship between neuroinflammation and cortical integrity. Methods: Mean 11C-PBR28 uptake was measured in focal cortical lesions, cortical areas with 7T quantitative T2* (q-T2*) abnormalities, and normal-appearing cortex. The relative difference in cortical 11C-PBR28 uptake between patients and 14 controls was used to classify cortical lesions as either active or inactive. Disease burden was investigated according to cortical lesion inflammatory profiles. The relation between q-T2* and 11C-PBR28 uptake along the cortex was assessed. Results: 11C-PBR28 uptake was abnormally high in cortical lesions in RRMS and SPMS; in SPMS, tracer uptake was significantly increased also in normal-appearing cortex. 11C-PBR28 uptake and q-T2* correlated positively in many cortical areas, negatively in some regions. Patients with high cortical lesion inflammation had worse clinical outcome and higher intracortical lesion burden than patients with low inflammation. Conclusion: 11C-PBR28 and 7T imaging reveal distinct profiles of cortical inflammation in MS, which are related to disease burden.


Sign in / Sign up

Export Citation Format

Share Document